المؤلفون: Jaymin B. Morjaria, Kesavan S. Babu

المصدر: Therapeutic Advances in Chronic Disease. 8:81-91

مصطلحات موضوعية: medicine.medical_specialty, Exacerbation, Reviews, Medicine (miscellaneous), 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Quality of life, Pharmacokinetics, Internal medicine, Medicine, 030212 general & internal medicine, COPD, biology, business.industry, Muscarinic antagonist, Lama, medicine.disease, biology.organism_classification, respiratory tract diseases, 030228 respiratory system, chemistry, Pharmacodynamics, Physical therapy, Vilanterol, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44e1fdde125ea4705f34566443fcbf73Test
https://doi.org/10.1177/2040622317700822Test

المؤلفون: James F. Donohue, Anthony D'Urzo, Kenneth R. Chapman, Dave Singh

المصدر: Therapeutic Advances in Respiratory Disease
Therapeutic Advances in Respiratory Disease, Vol 13 (2019)

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Adult, medicine.medical_specialty, Fixed-dose combination, formoterol, Review, Muscarinic Antagonists, Severity of Illness Index, 03 medical and health sciences, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Aclidinium bromide, Maintenance therapy, aclidinium, Internal medicine, Formoterol Fumarate, medicine, COPD, long-acting muscarinic antagonist, Humans, Pharmacology (medical), 030212 general & internal medicine, long-acting β2-agonist, Adrenergic beta-2 Receptor Agonists, lcsh:RC705-779, biology, maintenance treatment, business.industry, lcsh:Diseases of the respiratory system, Lama, medicine.disease, biology.organism_classification, Obstructive lung disease, 3. Good health, bronchodilators, Bronchodilator Agents, Drug Combinations, 030228 respiratory system, Quality of Life, Formoterol, business, medicine.drug, Tropanes

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a2e6e558b3eb232ce3210aff2bd5a26Test
http://europepmc.org/articles/PMC6535700Test

المؤلفون: M.K. Siddiqui, Mousumi Biswas, Mario Ouwens, Pragya Shukla, Deniz Guranlioglu, Patrick Darken, Martin Jenkins

المصدر: Therapeutic Advances in Respiratory Disease

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Agonist, medicine.drug_class, Network Meta-Analysis, Fixed-dose combination, Muscarinic Antagonists, Pharmacology, chronic obstructive pulmonary disease, Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, 0302 clinical medicine, Formoterol Fumarate, Administration, Inhalation, medicine, Humans, Pharmacology (medical), Metered Dose Inhalers, 030212 general & internal medicine, long-acting muscarinic antagonist (LAMA), Adrenergic beta-2 Receptor Agonists, Glycopyrrolate, Randomized Controlled Trials as Topic, COPD, business.industry, Muscarinic antagonist, medicine.disease, Metered-dose inhaler, fixed-dose combination, Drug Combinations, 030228 respiratory system, Meta-analysis, glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI), long-acting β2-agonist (LABA), business, Meta-Analysis, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1c9faf5c1c67af954183318e5d28bd0Test
https://doi.org/10.1177/1753466619894502Test

المؤلفون: Wang Chun Chen, Chau-Chyun Sheu, Ching Yi Chen, Kuo An Chu, Chi Hsien Huang, Meng-Chih Lin, Cheng Hung Lee, Yu-Feng Wei, Yi Ping Hsiang, Yung-Che Chen

المصدر: Therapeutic Advances in Respiratory Disease, Vol 14 (2020)

مصطلحات موضوعية: lcsh:RC705-779, Pulmonary and Respiratory Medicine, medicine.medical_specialty, COPD, biology, business.industry, Muscarinic antagonist, Pulmonary disease, lcsh:Diseases of the respiratory system, Lama, biology.organism_classification, medicine.disease, Fixed dose, 03 medical and health sciences, 0302 clinical medicine, 030228 respiratory system, Meta-analysis, Internal medicine, medicine, Pharmacology (medical), 030212 general & internal medicine, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be72a03375099736fa5ed1bf2063966dTest
https://doi.org/10.1177/1753466620937194Test

المؤلفون: Hiroaki Satoh, Nobuyuki Hizawa, Hideyasu Yamada, Taisuke Nakaizumi, Hideo Terashima, Norihito Hida

المصدر: Chronic Respiratory Disease

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Male, medicine.medical_specialty, Vital Capacity, MEDLINE, Pulmonary disease, Muscarinic Antagonists, Quinolones, 03 medical and health sciences, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Internal medicine, Forced Expiratory Volume, Soft-mist inhalers, Research Letter, Medicine, Humans, 030212 general & internal medicine, Tiotropium Bromide, Adrenergic beta-2 Receptor Agonists, Lung function, Aged, Aged, 80 and over, biology, business.industry, Chronic obstructive pulmonary disease, Inhalation Devices, Dry Powder Inhalers, Lama, biology.organism_classification, Glycopyrrolate, Benzoxazines, Long-acting muscarinic antagonist, Drug Combinations, 030228 respiratory system, Long-acting b2 agonist, Delayed-Action Preparations, Indans, Physical therapy, Dry-powder inhalers, Long-acting β2 agonist, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::079a2cb849925c1eb425958f96cc92edTest
https://tsukuba.repo.nii.ac.jp/records/44243Test